Stieva-a Forte

Stieva-a Forte Brand names, Stieva-a Forte Analogs

Stieva-a Forte Brand Names Mixture

No information avaliable

Stieva-a Forte Chemical_Formula

C₂₀H₂₈O₂

Stieva-a Forte RX_link

http://www.rxlist.com/cgi/generic/tretinoin.htm

Stieva-a Forte fda sheet

Stieva-a_Forte FDA

Stieva-a Forte msds (material safety sheet)

Stieva-a_Forte MSDS

Stieva-a Forte Synthesis Reference

Matsui et al.; J.Vitaminol.; 4; 190, 192(1958)

Stieva-a Forte Molecular Weight

300.435 g/mol

Stieva-a Forte Melting Point

181 ^oC

Stieva-a Forte H₂O Solubility

<0.1 g/100 mL

Stieva-a Forte State

Solid

Stieva-a Forte LogP

5.067

Stieva-a Forte Dosage Forms

Capsule; Cream; Gel; Liquid

Stieva-a Forte Indication

For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.

Stieva-a Forte Pharmacology

Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).

Stieva-a Forte Absorption

1-31% (topical);

Stieva-a Forte side effects and Toxicity

No information avaliable

Stieva-a Forte Patient Information